Albert Banal-Estañol, Inés Macho-Stadler, and David Pérez-Castrillo answer key questions about the funding process within a unified framework.
Albert Banal-Estañol, Melissa Newham, and Jo Seldeslachts provide evidence on the impact of common ownership on generic drug entry in US pharmaceutical markets.
Albert Banal-Estañol, Inés Macho-Stadler and David Pérez-Castrillo show that if we want to avoid missing the next academic Beatles, we cannot just “let it be.”
Albert Banal-Estañol, Inés Macho-Stadler, and David Pérez-Castrillo study collaboration between academics and firms. They are the first to provide a one-to-one two-sided matching market model of academic researchers and firms developing research projects.